-
公开(公告)号：DK1001930T3
公开(公告)日：2003-03-24
申请号：DK98936014
申请日：1998-07-27
Applicant: ABBOTT LAB
Inventor： CURTIN MICHAEL L , DAVIDSEN STEVEN K , DELLARIA JOSEPH F JR , GIESLER JAMIE , GUO YAN , HEYMAN H ROBIN , HOLMS JAMES H , STEINMAN DOUGLAS H , WADA CAROL K , FLORJANCIC ALAN S , MICHAELIDES MICHAEL R , XU LIANHONG , GONG JIANCHUN
IPC: C07D233/74 , A61K31/275 , A61K31/351 , A61K31/352 , A61K31/4035 , A61K31/4166 , A61K31/4178 , A61K31/421 , A61K31/428 , A61K31/4439 , A61K31/4465 , A61K31/45 , A61K31/454 , A61K31/50 , A61P1/02 , A61P1/04 , A61P19/02 , A61P19/10 , A61P29/00 , A61P35/00 , A61P43/00 , C07C259/06 , C07C311/05 , C07C311/18 , C07C317/28 , C07C317/40 , C07C323/47 , C07C323/62 , C07D207/40 , C07D207/404 , C07D207/416 , C07D209/48 , C07D211/88 , C07D213/68 , C07D233/76 , C07D233/78 , C07D237/14 , C07D263/44 , C07D275/04 , C07D275/06 , C07D309/14 , C07D311/18 , C07D401/06 , C07D401/12 , C07D405/12 , C07D409/12 , C07C259/00
Abstract: Compounds having formula (I) are matrix metalloproteinase inhibitors. Also disclosed are matrix metalloproteinase-inhibiting compositions and methods of inhibiting matrix metalloproteinase in a mammal.
-
公开(公告)号：AT228998T
公开(公告)日：2002-12-15
申请号：AT98936014
申请日：1998-07-27
Applicant: ABBOTT LAB
Inventor： CURTIN MICHAEL L , DAVIDSEN STEVEN K , DELLARIA JOSEPH F JR , FLORJANCIC ALAN S , GIESLER JAMIE , GONG JIANCHUN , GUO YAN , HEYMAN H ROBIN , HOLMS JAMES H , MICHAELIDES MICHAEL R , STEINMAN DOUGLAS H , WADA CAROL K , XU LIANHONG
IPC: C07D233/74 , A61K31/275 , A61K31/351 , A61K31/352 , A61K31/4035 , A61K31/4166 , A61K31/4178 , A61K31/421 , A61K31/428 , A61K31/4439 , A61K31/4465 , A61K31/45 , A61K31/454 , A61K31/50 , A61P1/02 , A61P1/04 , A61P19/02 , A61P19/10 , A61P29/00 , A61P35/00 , A61P43/00 , C07C259/06 , C07C311/05 , C07C311/18 , C07C317/28 , C07C317/40 , C07C323/47 , C07C323/62 , C07D207/40 , C07D207/404 , C07D207/416 , C07D209/48 , C07D211/88 , C07D213/68 , C07D233/76 , C07D233/78 , C07D237/14 , C07D263/44 , C07D275/04 , C07D275/06 , C07D309/14 , C07D311/18 , C07D401/06 , C07D401/12 , C07D405/12 , C07D409/12 , C07C259/00
Abstract: Compounds having formula (I) are matrix metalloproteinase inhibitors. Also disclosed are matrix metalloproteinase-inhibiting compositions and methods of inhibiting matrix metalloproteinase in a mammal.
-
公开(公告)号：NO996579D0
公开(公告)日：1999-12-30
申请号：NO996579
申请日：1999-12-30
Applicant: ABBOTT LAB
Inventor： CURTIN MICHAEL L , DAVIDSEN STEVEN K , DELLARIA JOSEPH F , FLORJANCIC ALAN S , GIESLER JAMIE , GONG JIANCHUN , GUO YAN , HEYMAN H ROBIN , HOLMS JAMES H , MICHAELIDES MICHAEL R , STEINMAN DOUGLAS , WADA CAROL K , XU LIANHONG
IPC: C07D233/74 , A61K31/275 , A61K31/351 , A61K31/352 , A61K31/4035 , A61K31/4166 , A61K31/4178 , A61K31/421 , A61K31/428 , A61K31/4439 , A61K31/4465 , A61K31/45 , A61K31/454 , A61K31/50 , A61P1/02 , A61P1/04 , A61P19/02 , A61P19/10 , A61P29/00 , A61P35/00 , A61P43/00 , C07C259/06 , C07C311/05 , C07C311/18 , C07C317/28 , C07C317/40 , C07C323/47 , C07C323/62 , C07D207/40 , C07D207/404 , C07D207/416 , C07D209/48 , C07D211/88 , C07D213/68 , C07D233/76 , C07D233/78 , C07D237/14 , C07D263/44 , C07D275/04 , C07D275/06 , C07D309/14 , C07D311/18 , C07D401/06 , C07D401/12 , C07D405/12 , C07D409/12 , C07C
Abstract: Compounds having formula (I) are matrix metalloproteinase inhibitors. Also disclosed are matrix metalloproteinase-inhibiting compositions and methods of inhibiting matrix metalloproteinase in a mammal.
-
公开(公告)号：CA2277121A1
公开(公告)日：1998-07-16
申请号：CA2277121
申请日：1998-01-07
Applicant: ABBOTT LAB
Inventor： DAVIDSEN STEVEN K , FLORJANCIC ALAN SCOTT , STEINMAN DOUGLAS H , GUO YAN , HOLMS JAMES H , SHEPPARD GEORGE S , XU LIANHONG , MICHAELIDES MICHAEL R , SUMMERS JAMES B
IPC: A61K31/55 , A61K38/05 , C07D225/06 , C07D245/02 , C07D245/06 , C07D255/02 , C07D267/00 , C07D413/04 , C07D413/06 , C07D417/06 , C07D487/08 , C07K5/078
Abstract: Macrocyclic compounds of formula (I) are potent inhibitors of matrix metalloproteinase and are useful in the treatment of diseases in which matrix metalloproteinase play a role. Also disclosed are matrix metalloproteinase inhibiting compositions and a method of inhibiting matrix metalloproteinase in a mammal.
-
公开(公告)号：ZA9800020B
公开(公告)日：1998-07-02
申请号：ZA9800020
申请日：1998-01-02
Applicant: ABBOTT LAB
Inventor： DAVIDSEN STEVEN K , SHEPPARD GEORGE S , HOLMS JAMES H , FLORJANCIC ALAN S , MICHAELIDES MICHAEL R , STEINMAN DOUGLAS H , XU LIANHONG , GUO YAN , SUMMERS JAMES B
IPC: A61K31/395 , A61K31/40 , A61K31/404 , A61K31/4188 , A61K31/427 , A61K31/4427 , A61K31/4523 , A61K31/553 , A61K38/00 , A61K38/55 , A61P1/02 , A61P7/00 , A61P11/06 , A61P19/02 , A61P19/10 , A61P27/02 , A61P29/00 , A61P35/00 , A61P43/00 , C07D225/06 , C07D245/02 , C07D245/06 , C07D267/00 , C07D273/01 , C07D413/04 , C07D413/06 , C07D413/12 , C07D417/06 , C07D417/12 , C07D487/08 , C07K5/078 , C07D , A61K
CPC classification number: C07D413/04 , C07D225/06 , C07D245/02 , C07D245/06 , C07D267/00 , C07D413/06 , C07D417/06 , C07D487/08 , C07K5/06139
-
Patent Agency Ranking
公开(公告)号：ZA9800018B
公开(公告)日：1998-07-02
申请号：ZA9800018
申请日：1998-01-02
Applicant: ABBOTT LAB
Inventor： DAVIDSEN STEVEN K , SHEPPARD GEORGE S , XU LIANHONG , CURTIN MICHAEL L , WADA CAROL K , FLORJANCIC ALAN SCOTT , GIESLER JAMIE R , GUO YAN , MICHAELIDES MICHAEL R , HOLMS JAMES H
IPC: A61K31/165 , A61K31/197 , A61K31/381 , A61K31/404 , A61K31/4184 , A61K31/421 , A61K31/426 , A61K31/4406 , A61P19/02 , A61P19/10 , A61P29/00 , A61P35/00 , A61P43/00 , C07C233/32 , C07C259/06 , C07D207/32 , C07D207/323 , C07D207/335 , C07D209/14 , C07D213/50 , C07D235/14 , C07D263/32 , C07D277/24 , C07D277/28 , C07D277/30 , C07D333/22 , C07F , A61K , C07C
CPC classification number: C07D207/335 , C07B2200/07 , C07C233/32 , C07C259/06 , C07C2601/14 , C07D209/14 , C07D213/50 , C07D235/14 , C07D263/32 , C07D277/28 , C07D333/22
-
公开(公告)号：PE20040267A1
公开(公告)日：2004-05-01
申请号：PE2003000283
申请日：2003-03-21
Applicant: ABBOTT LAB
Inventor： CURTIN MICHAEL , DAI YUHIA , DAVIDSEN STEVEN K , MICHAELIDES MICHAEL R , GUO YAN , JI ZHIQIN , FREY ROBIN R
IPC: C07D495/04 , A61K31/519 , A61P1/04 , A61P3/10 , A61P5/14 , A61P7/10 , A61P9/10 , A61P9/12 , A61P11/00 , A61P17/06 , A61P19/02 , A61P21/04 , A61P25/00 , A61P29/00 , A61P35/00 , A61P35/02 , A61P37/06 , A61P43/00 , C07D498/02 , C07D513/04
Abstract: SE REFIERE DERIVADOS DE TIOPIRIMIDINAS E ISOTIAZOLPIRIMIDINAS INHIBIDORAS DE QUINASAS DE FORMULA (I) DONDE X ES -N- Y -CR3-; Z1 ES -N- Y -CR4; Z2 ES -N- Y CR5; Z3 ES -N- Y CR6; Z4 ES -N- Y CR7-; R1 ES H Y NH2; R2 ES ALCOXI, CIANO, HIDROXI, NITRO,-NRaRb Y -LR8; R3 ES H, ALQUENILO, ALCOXIALQUILO, ALQUILO, ARILALQUILO, CARBOXIALQUILO, HALO, HALOALQUILO, HETEROARILALQUILO, (HETEROCICLIL)ALQUILO, HIDROXIALQUILO, (NRaRb)ALQUILO Y (NRaRb)C(O)ALQUILO; R4, R5, R6, Y R7 ES H, ALCOXI, ALQUILO, NRaRb, HALO Y HIDROXI; R8 ES ALCOXIALQUILO, ALQUILO, ARILO, CICLOALQUILO, HETEROALQUILO, ENTRE OTROS; L ES -O-, -(CH2)nC(O)(CH2)p-, C=C-, (CH2)nO-, -C(O)NR9-, -NR9C(O)-, -NR9-, -(CH2)nNR9C(O)NR10(CH2)p-, -NR9C(S)NR10-, NR9C(=NCN)O, ENTRE OTROS. DONDE R9 Y R10 ES H, ALQUILO; m, n y p SON 0-2, CON LA SALVEDAD DE QUE AL MENOS UN Z1, Z2, Z3 Y Z4 SEA DISTINTO DE N. SON COMPUESTOS PREFERIDOS: N-[4-(4-AMINOTIEN[2,3-d]PIRIMIDIN-5-IL)FENIL]-N'-[2-FLUORO-5-(TRIFLUOROMETIL)FENIL]UREA; N-[4-(4-AMINOTIEN[2,3-d]PIRIMIDIN-5-IL)FENIL]-N'-(3-METILFENIL)UREA.LOS COMPUESTOS TIENEN ACTIVIDAD INHIBITORIA DE LAS PTK ESPECIFICAS (PROTEINA TIROSINA KINASA) COMO KDR Y Tie-2.TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA Y A UN METODO DE OBTENCION. ESTOS COMPUESTOS SON UTILES PARA EL TRATAMIENTO DEL CANCER.
-
28.发明专利
公开(公告)号：NZ501166A
公开(公告)日：2001-12-21
申请号：NZ50116698
申请日：1998-07-27
Applicant: ABBOTT LAB
Inventor： HOLMS JAMES H , STEINMAN DOUGLAS , XU LIANGHONG , CURTIN MICHAEL L , FLORJANCIC ALAN S , GONG JIANCHUN , HEYMAN H ROBERT , MICHAELIDES MICHAEL R , WADA CAROL K , DAVIDSEN STEVEN K , DELLARIA JOSEPH F , GIESER JAMIE , GUO YAN
IPC: C07D233/74 , A61K31/275 , A61K31/351 , A61K31/352 , A61K31/4035 , A61K31/4166 , A61K31/4178 , A61K31/421 , A61K31/428 , A61K31/4439 , A61K31/4465 , A61K31/45 , A61K31/454 , A61K31/50 , A61P1/02 , A61P1/04 , A61P19/02 , A61P19/10 , A61P29/00 , A61P35/00 , A61P43/00 , C07C259/06 , C07C311/05 , C07C311/18 , C07C317/28 , C07C317/40 , C07C323/47 , C07C323/62 , C07D207/40 , C07D207/404 , C07D207/416 , C07D209/48 , C07D211/88 , C07D213/68 , C07D233/76 , C07D233/78 , C07D237/14 , C07D263/44 , C07D275/04 , C07D275/06 , C07D309/14 , C07D311/18 , C07D401/06 , C07D401/12 , C07D405/12 , C07D409/12 , A61K31/165 , A61K31/277 , A61K31/425 , A61K31/18 , A61K31/4015 , A61K31/42 , A61K31/44
Abstract: A compound of formula (I) or a pharmaceutically acceptable salt or prodrug thereof, wherein: A is H; n is zero; R1 and R3 are independently H or alkyl; R2 and R4 are independently H; alkyl; alkenyl; alkoxyalkyl; alkoxycarbonylalkyl; haloalkyl; hydroxyalkyl; (alkylene)-S(O)p-alkyl; phenyl; phenylalkoxyalkyl; phenylalkyl; phenoxyalkyl; -(alkylene)-N(R5)S02-phenyl; (heterocycle)oxyalkyl; -(alkylene)-S(O)p-heterocycle; -(alkylene)-heterocycle; or -(alkylene)-NR6R7 or R1 and R2, taken together with the carbon atom to which they are attached form a ring selected from spiroalkyl of 3 to 8 carbon atoms and tetrahydropyranyl; or R3 and R4, taken together with the carbon atom to which they are attached, form a spiroalkyl group of 3 to 8 carbon atoms; or R1 and R3 taken together with the carbon atoms to which they are attached are a 5, 6, or 7-membered carbocyclic ring; X is -0-; -NR5S02-; -S(O)p-; or -C(O)-; wherein each group is drawn with its left-hand end being the end which attaches to the alkylene group and its right-hand end being the end which attaches to Ar1; Ar1 is optionally substituted phenyl; Y is a covalent bond, -O-, alkylene, piperidinyl, alkenylene of two carbon atoms, alkynylene of two carbon atoms, -S(0)p- or -C(O)-; and Ar2 is an optionally substituted aryl group selected from the group consisting of phenyl; pyridyl; pyrazinyl; pyridazinyl; furyl; thienyl; isoxazolyl; oxazolyl; thiazolyl and isothiazolyl; All other variables are as defined in the specification. A pharmaceutical composition comprising the compound of formula (I) and a pharmaceutically acceptable carrier is also described. The compound of formula (I) is used for inhibiting matrix metalloproteinases in mammals.
-
公开(公告)号：BR9810760A
公开(公告)日：2001-11-27
申请号：BR9810760
申请日：1998-07-27
Applicant: ABBOTT LAB
Inventor： CURTIN MICHAEL L , DAVIDSEN STEVEN K , DELLARIA JOSEPH F , FLORJANCIC ALAN S , GIESLER JAMIE , GONG JIANCHUN , GUO YAN , HEYMAN H ROBIN , HOLMS JAMES H , MICHAELIDES MICHAEL R , STEINMAN DOUGLAS H , WADA CAROL K , XU LIANHONG
IPC: C07D233/74 , A61K31/275 , A61K31/351 , A61K31/352 , A61K31/4035 , A61K31/4166 , A61K31/4178 , A61K31/421 , A61K31/428 , A61K31/4439 , A61K31/4465 , A61K31/45 , A61K31/454 , A61K31/50 , A61P1/02 , A61P1/04 , A61P19/02 , A61P19/10 , A61P29/00 , A61P35/00 , A61P43/00 , C07C259/06 , C07C311/05 , C07C311/18 , C07C317/28 , C07C317/40 , C07C323/47 , C07C323/62 , C07D207/40 , C07D207/404 , C07D207/416 , C07D209/48 , C07D211/88 , C07D213/68 , C07D233/76 , C07D233/78 , C07D237/14 , C07D263/44 , C07D275/04 , C07D275/06 , C07D309/14 , C07D311/18 , C07D401/06 , C07D401/12 , C07D405/12 , C07D409/12 , C07C259/00
Abstract: Compounds having formula (I) are matrix metalloproteinase inhibitors. Also disclosed are matrix metalloproteinase-inhibiting compositions and methods of inhibiting matrix metalloproteinase in a mammal.
-
公开(公告)号：HK1028023A1
公开(公告)日：2001-02-02
申请号：HK00107516
申请日：2000-11-23
Applicant: ABBOTT LAB
Inventor： CURTIN MICHAEL L , DAVIDSEN STEVEN K , DELLARIA JOSEPH F JR , FLORJANCIC ALAN S , GIESLER JAMIE , GONG JIANCHUN , GUO YAN , HEYMAN H ROBIN , HOLMS JAMES H , MICHAELIDES MICHAEL R , STEINMAN DOUGLAS H , WADA CAROL K , XU LIANHONG
IPC: C07D233/74 , A61K31/275 , A61K31/351 , A61K31/352 , A61K31/4035 , A61K31/4166 , A61K31/4178 , A61K31/421 , A61K31/428 , A61K31/4439 , A61K31/4465 , A61K31/45 , A61K31/454 , A61K31/50 , A61P1/02 , A61P1/04 , A61P19/02 , A61P19/10 , A61P29/00 , A61P35/00 , A61P43/00 , C07C259/06 , C07C311/05 , C07C311/18 , C07C317/28 , C07C317/40 , C07C323/47 , C07C323/62 , C07D207/40 , C07D207/404 , C07D207/416 , C07D209/48 , C07D211/88 , C07D213/68 , C07D233/76 , C07D233/78 , C07D237/14 , C07D263/44 , C07D275/04 , C07D275/06 , C07D309/14 , C07D311/18 , C07D401/06 , C07D401/12 , C07D405/12 , C07D409/12 , C07C
Abstract: Compounds having formula (I) are matrix metalloproteinase inhibitors. Also disclosed are matrix metalloproteinase-inhibiting compositions and methods of inhibiting matrix metalloproteinase in a mammal.
-
-
-
-
-
-
-
-
-
Search Results
47
records
(took 0.033 seconds)
